oxacillin has been researched along with mbi-226 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fedler, KA; Jones, RN; Rennie, RP; Sader, HS; Stevens, S | 1 |
1 other study(ies) available for oxacillin and mbi-226
Article | Year |
---|---|
Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteria; Bacterial Infections; Candida; Candidiasis; Colony Count, Microbial; Drug Stability; Freezing; Humans; Kinetics; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Vancomycin Resistance | 2004 |